Skip to content

Study on clinical application of transcutaneous electrical acupoint stimulation in preventing lower extremity deep vein thrombosis in patients with stroke

Study on clinical application of transcutaneous electrical acupoint stimulation in preventing lower extremity deep vein thrombosis in patients with stroke - Study on clinical application of transcutaneous electrical acupoint stimulation in preventing lower extremity deep vein thrombosis in patients with stroke

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400081395
Enrollment
Unknown
Registered
2024-02-29
Start date
2024-03-01
Completion date
Unknown
Last updated
2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hemorrhagic stroke

Interventions

Group A:All patients with hemorrhagic stroke enrolled in the group were given routine nursing, including psychological nursing, positional nursing (regular turning over and percussion), dietary nursin
Group B:On the basis of routine nursing, from the first day after the patient was admitted to the ward, the patient was treated with an electric stimulator, and the Jiguan acupoint, Xuehai acupoint, S
Group C:On the basis of routine nursing, from the first day after the patient was admitted to the ward, the patient was treated with an electric stimulator, and the Jiguan acupoint, Xuehai ac

Sponsors

The Second Affiliated Hospital of the University of South China
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: (1) Meet the above diagnostic criteria for hemorrhagic stroke; (2) Age 18~75 years old, gender, occupation, ethnicity is not limited; (3) Patients and their families voluntarily participate in this study and sign the informed consent form.

Exclusion criteria

Exclusion criteria: (1) Patients who have been suffered from LEDVT by color ultrasound examination before enrollment; (2) Those who have lower limb vascular diseases and lower limb skin defects, death, or fractures before admission, and who need surgery on the lower limbs recently; (3) Patients with poor compliance and refusal to cooperate; (4) Use of oral or subcutaneous anticoagulant drugs, such as rivaroxaban, warfarin, low molecular weight heparin, etc., during the study; ? (5) Treatment of local skin abnormalities at acupuncture points or allergies to electrodes and conductive adhesives, such as ulceration, gangreus, dermatitis, recent skin graft surgery, etc.; ? (6) Combined with other diseases that seriously affect the quality of life and/or seriously affect the quality of investigation, such as mental abnormalities and Alzheimer's disease, etc., those who cannot cooperate; (7) Patients who cannot tolerate transcutaneous acupoint electrical stimulation operations; (8) Those who are equipped with a pacemaker or implanted steel nails or plates that have an impact on the current; (9) Patients who have been hospitalized for less than 14 days.

Design outcomes

Primary

MeasureTime frame
Whether venous thrombosis of the lower extremities has occurred;

Secondary

MeasureTime frame
homocysteine;D-dimer;Prothrombin time;fibrinogen;INR;Platelet count;

Countries

China

Contacts

Public ContactYin Ting

The Second Affiliated Hospital of the University of South China

1179338301@qq.com+86 150 7479 9747

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026